Both these therapeutic pathways may be inert properties of MSCs and hypothermia, but may also be facilitated by delta opioids outside the ligand-receptor regulatory mechanism, as seen in GDNF upregulation and suppression of apoptotic cell death in DADLE-treated experimental stroke animals [16]. Here, GDNF is linked to stroke disorder.